Long-Acting β-Agonists With vs Without Inhaled Corticosteroids for COPD Reply

被引：1
作者：
Gershon, Andrea S. [1 ,2 ]
Campitelli, Michael A. [2 ]
Stanbrook, Matthew B. [3 ]
机构：
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[3] Univ Toronto, Div Respirol, Toronto, ON, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 03期
关键词：
RISK;
D O I：
10.1001/jama.2014.16479
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [41] Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
    Mathioudakis, Alexander G.
    Bikov, Andras
    Foden, Philip
    Lahousse, Lies
    Brusselle, Guy
    Singh, Dave
    Vestbo, Jorgen
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [42] An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
    Alakeel, Yousif S.
    Khader, Esraa
    Altuwayli, Norah
    Alrammah, Shahad
    Abdel-Razaq, Wesam
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (03) : 300 - 305
  • [43] One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study
    Kirchmayer, Ursula
    Cascini, Silvia
    Agabiti, Nera
    Di Martino, Mirko
    Bauleo, Lisa
    Formoso, Giulio
    Voci, Claudio
    Pistelli, Riccardo
    Patorno, Elisabetta
    Davoli, Marina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (05) : 578 - 589
  • [44] Changing patterns of medication prescription for COPD patients in France. Impact of long-acting muscarinic antagonists' availability
    Jebrak, G.
    Burgel, P. -R.
    Caillaud, D.
    Deslee, G.
    Brinchault, G.
    Chanez, P.
    Court-Fortune, I.
    Escamilla, R.
    Nesme-Meyer, P.
    Pinet, C.
    Perez, T.
    Paillasseur, J. -L.
    Roche, N.
    REVUE DES MALADIES RESPIRATOIRES, 2017, 34 (05) : 535 - 543
  • [45] Comparison of Inhaled Long-Acting β-Agonist and Anticholinergic Effectiveness in Older Patients With Chronic Obstructive Pulmonary Disease A Cohort Study
    Gershon, Andrea
    Croxford, Ruth
    To, Teresa
    Stanbrook, Matthew B.
    Upshur, Ross
    Sanchez-Romeu, Paula
    Stukel, Therese
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) : 583 - 592
  • [46] Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
    Welsh, Emma J.
    Cates, Christopher J.
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [47] Comparative Safety of Long-Acting vs. Short-Acting Erythropoiesis-Stimulating Agents Among Patients Undergoing Hemodialysis
    Desai, Raj
    Unigwe, Ikenna
    Riaz, Munaza
    Smith, Steven M.
    Shukla, Ashutosh M.
    Mohandas, Rajesh
    Jeon, Nakyung
    Park, Haesuk
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 217 - 224
  • [48] Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis
    Lee, Hyun Woo
    Kim, Hyung Jun
    Jang, Eun Jin
    Lee, Chang-Hoon
    RESPIRATION, 2021, 100 (07) : 631 - 643
  • [49] Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease
    Arfe, Andrea
    Nicotra, Federica
    Cerveri, Isa
    de Marco, Roberto
    Vaghi, Adriano
    Merlino, Luca
    Corrao, Giovanni
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (05) : 540 - 546
  • [50] Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma
    Stanford, Richard H.
    Averell, Carlyne
    Parker, Emily D.
    Blauer-Peterson, Cori
    Reinsch, Tyler K.
    Buikema, Ami R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (05) : 1488 - +
12345